Foundation Medicine, Inc. (NASDAQ: FMI) today announced the presentation of new findings at the American Association for Cancer Research (AACR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment StrategiesApril 11, 2018 7:00 AM